BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 10967568)

  • 1. Tuberculosis after hematopoietic stem cell transplantation: incidence, clinical characteristics and outcome. Spanish Group on Infectious Complications in Hematopoietic Transplantation.
    de la Cámara R; Martino R; Granados E; Rodriguez-Salvanés FJ; Rovira M; Cabrera R; López J; Parody R; Sierra J; Fernández-Rañada JM; Carreras E
    Bone Marrow Transplant; 2000 Aug; 26(3):291-8. PubMed ID: 10967568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycobacterial infection: a difficult and late diagnosis in stem cell transplant recipients.
    Cordonnier C; Martino R; Trabasso P; Held TK; Akan H; Ward MS; Fabian K; Ullmann AJ; Wulffraat N; Ljungman P; Alessandrino EP; Pretnar J; Gmür J; Varela R; Vitek A; Sica S; Rovira M;
    Clin Infect Dis; 2004 May; 38(9):1229-36. PubMed ID: 15127333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.
    Anagnostopoulos A; Hari PN; Pérez WS; Ballen K; Bashey A; Bredeson CN; Freytes CO; Gale RP; Gertz MA; Gibson J; Goldschmidt H; Lazarus HM; McCarthy PL; Reece DE; Vesole DH; Giralt SA
    Biol Blood Marrow Transplant; 2006 Aug; 12(8):845-54. PubMed ID: 16864055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
    Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
    Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary failure of platelet recovery after hematopoietic stem cell transplantation.
    Bruno B; Gooley T; Sullivan KM; Davis C; Bensinger WI; Storb R; Nash RA
    Biol Blood Marrow Transplant; 2001; 7(3):154-62. PubMed ID: 11302549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autologous and allogeneic stem cell transplantation in adult ALL: the Swedish Adult ALL Group experience.
    Hallböök H; Hägglund H; Stockelberg D; Nilsson PG; Karlsson K; Björkholm M; Linderholm M; Wahlin A; Linder O; Smedmyr B;
    Bone Marrow Transplant; 2005 Jun; 35(12):1141-8. PubMed ID: 15834433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of tuberculosis after bone marrow transplantation in a single center from Turkey.
    Arslan O; Gürman G; Dilek I; Ozcan M; Koç H; Ilhan O; Akan H; Konuk N; Uysal A; Beksaç M
    Haematologia (Budap); 1998; 29(1):59-62. PubMed ID: 9704259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The harvest and use of autologous back-up grafts for graft failure or severe GVHD after allogeneic hematopoietic stem cell transplantation: a survey of the European Group for Blood and Marrow Transplantation.
    Stelljes M; van Biezen A; Slavin S; Olavarria E; Clark RE; Nagler A; Koza V; Kienast J; Niederwieser D; de Witte T; Ruutu T;
    Bone Marrow Transplant; 2008 Dec; 42(11):739-42. PubMed ID: 18724394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified conditioning regimen busulfan-cyclophosphamide followed by allogeneic stem cell transplantation in patients with multiple myeloma.
    Zhang XH; Huang XJ; Liu KY; Xu LP; Liu DH; Chen H; Chen YH; Wang JZ; Han W; Lu DP
    Chin Med J (Engl); 2007 Mar; 120(6):463-8. PubMed ID: 17439737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial.
    Gómez-Núñez M; Martino R; Caballero MD; Pérez-Simón JA; Canals C; Mateos MV; Sarrá J; León A; Solano C; Moraleda JM; Urbano-Ispizua A; Besalduch J; Miguel JS; Sierra J
    Bone Marrow Transplant; 2004 Mar; 33(5):477-82. PubMed ID: 14730333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis in blood and marrow transplant recipients.
    Yuen KY; Woo PC
    Hematol Oncol; 2002 Jun; 20(2):51-62. PubMed ID: 12111868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.
    Kuruvilla J; Shepherd JD; Sutherland HJ; Nevill TJ; Nitta J; Le A; Forrest DL; Hogge DE; Lavoie JC; Nantel SH; Toze CL; Smith CA; Barnett MJ; Song KW
    Biol Blood Marrow Transplant; 2007 Aug; 13(8):925-31. PubMed ID: 17640596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central nervous system complications after allogeneic hematopoietic stem cell transplantation: incidence, manifestations, and clinical significance.
    Siegal D; Keller A; Xu W; Bhuta S; Kim DH; Kuruvilla J; Lipton JH; Messner H; Gupta V
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1369-79. PubMed ID: 17950923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant.
    Martino R; Caballero MD; de la Serna J; Díez-Martín JL; Urbano-Ispízua A; Tomás JF; Odriozola J; León A; Canals C; San Miguel J; Sierra J
    Bone Marrow Transplant; 2002 Jul; 30(2):63-8. PubMed ID: 12132043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late-onset non-infectious pulmonary complications following allogeneic hematopoietic stem cell transplantation in children.
    Nishio N; Yagasaki H; Takahashi Y; Muramatsu H; Hama A; Tanaka M; Yoshida N; Watanabe N; Kudo K; Yoshimi A; Kojima S
    Bone Marrow Transplant; 2009 Sep; 44(5):303-8. PubMed ID: 19349954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparison of autologous and allogeneic hematopoietic stem cell transplantation for 140 patients with de novo acute leukemia in first complete remission].
    Wang HH; Feng SZ; Wang M; Wei JL; Jiang EL; Zhang L; Huang Y; Zhou SY; Liu QG; Qiu LG; Han MZ; Yan WW
    Zhonghua Xue Ye Xue Za Zhi; 2004 Jul; 25(7):389-92. PubMed ID: 15355688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F
    Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.